Freya Biosciences
Developer of microbial immunotherapies designed to address substantial unmet needs across a range of indications. The company uses a proprietary approach to engineer and provide live microbes that are...
Valuation
$65.7M
Latest known
Share Price
N/A
Total Raised
$66.5M
Last Round
N/A